These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 4829566

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Nitrofurantoin: particle size and dissolution.
    Eyjolfsson R.
    Drug Dev Ind Pharm; 1999 Jan; 25(1):105-6. PubMed ID: 10028426
    [Abstract] [Full Text] [Related]

  • 24. Clinical bioavaiability of nitrofurantoin--a case of bioinequivalence.
    DiSanto AR, Chodos DJ, Phillips JP, DeSante KA, Stoll RG.
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):220-7. PubMed ID: 950266
    [Abstract] [Full Text] [Related]

  • 25. Urinary drug excretion in dogs during therapeutic doses of different nitrofurantoin dosage forms.
    Conklin JD, Sobers RJ, Wagner DL.
    J Pharm Sci; 1969 Nov; 58(11):1365-8. PubMed ID: 5349751
    [No Abstract] [Full Text] [Related]

  • 26. Studies on freeze-dried drug-milk formulations. II: Effect of regenerated fluid volume on nitrofurantoin bioavailability.
    Macheras PE, Reppas CI.
    J Pharm Sci; 1986 Dec; 75(12):1145-50. PubMed ID: 3559923
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effect of formulation and process variables on bioequivalency of nitrofurantoin II: in vivo-in vitro correlation.
    Mendes RW, Masih SZ, Kanumuri RR.
    J Pharm Sci; 1978 Nov; 67(11):1616-9. PubMed ID: 712603
    [Abstract] [Full Text] [Related]

  • 29. [Letter: Poisoning paresis of the lower extremities following short-time use of furadantin (nitrofurantoin)].
    Maehlumshagen G, Andlem L.
    Tidsskr Nor Laegeforen; 1975 Apr 10; 95(10):627. PubMed ID: 1135799
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Sustained-release microcapsules of nitrofurantoin and amoxicillin; preparation, in-vitro release rate, kinetic and micromeritic studies.
    Ertan G, Ozer O, Baloğlu E, Güneri.
    J Microencapsul; 1997 Apr 10; 14(3):379-88. PubMed ID: 9147286
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Nitrofurantoin enteric pellets with high bioavailability based on aciform crystalline formation by wet milling.
    Yu H, Pan L, Li P, Zhang K, Lin X, Zhang Y, Tang X.
    Pharm Dev Technol; 2015 Jun 10; 20(4):433-41. PubMed ID: 24467214
    [Abstract] [Full Text] [Related]

  • 34. Sustained release nitrofurantoin tablets by direct compression.
    Conte U, Colombo P, Caramella C, La Manna A.
    Farmaco Prat; 1979 Jul 10; 34(7):306-16. PubMed ID: 467625
    [No Abstract] [Full Text] [Related]

  • 35. [Effectiveness, tolerance, and urinary elimination of selected nitrofurantoin crystals].
    Crespi F, Raimondi GF, Bulletti G, Zoni G.
    Minerva Med; 1969 Dec 12; 60(99):4979-84. PubMed ID: 5363065
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pluronic-g-poly(acrylic acid) copolymers as novel excipients for site specific, sustained release tablets.
    Barreiro-Iglesias R, Bromberg L, Temchenko M, Hatton TA, Alvarez-Lorenzo C, Concheiro A.
    Eur J Pharm Sci; 2005 Dec 12; 26(5):374-85. PubMed ID: 16165345
    [Abstract] [Full Text] [Related]

  • 38. [A comparative study on the absorption of drugs after oral, rectal and parenteral application. 3. Nitrofurantoin].
    Huizinga T, van Haeringen A.
    Pharm Weekbl; 1969 Jun 27; 104(26):588-94. PubMed ID: 5789005
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.